Importantly, we revealed that FTO operates through a regulatory network of m6A modifications that involves METTL14, YTHDF1 and AKT3 signaling, providing the first insight into the mechanism of FTO-mediated esophageal cancer progression. The gene discussed is AKT3; the disease is esophageal cancer.